Evidence map›Paper›PMID 29548335›Full record

ArticleGenome biology2018

Mutational signatures reveal the role of RAD52 in p53-independent p21-driven genomic instability.

Panagiotis Galanos, George Pappas, Alexander Polyzos, Athanassios Kotsinas, Ioanna Svolaki, Nickolaos N Giakoumakis, Christina Glytsou, Ioannis S Pateras, Umakanta Swain, Vassilis L Souliotis and 11 more

Erratum issuedOpen access · goldAbstract readVideo-Audio Media
In one paragraph

Article in Genome biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Targeting KMT5C Suppresses Lung Cancer Progression and Enhances the Efficacy of Immunotherapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Revisiting the Function of p21International journal of molecular sciences · 2022
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. The Role ofInternational journal of molecular sciences · 2021
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 11 institutions in 7 countries.

Panagiotis GalanosMolecular Carcinogenesis Group, Department of Histology and Embryology, School of Medicine, National Kapodistrian University of Athens, 75 Mikras Asias Str, GR-11527, Athens, Greece.
George PappasMolecular Carcinogenesis Group, Department of Histology and Embryology, School of Medicine, National Kapodistrian University of Athens, 75 Mikras Asias Str, GR-11527, Athens, Greece.
Alexander PolyzosBiomedical Research Foundation of the Academy of Athens, 4 Soranou Ephessiou Str, GR-11527, Athens, Greece.
Athanassios KotsinasMolecular Carcinogenesis Group, Department of Histology and Embryology, School of Medicine, National Kapodistrian University of Athens, 75 Mikras Asias Str, GR-11527, Athens, Greece.
Ioanna SvolakiMolecular Carcinogenesis Group, Department of Histology and Embryology, School of Medicine, National Kapodistrian University of Athens, 75 Mikras Asias Str, GR-11527, Athens, Greece.
Nickolaos N GiakoumakisLaboratory of Biology, School of Medicine, University of Patras, 26505, Patras, Rio, Greece.
Christina GlytsouDepartment of Biology, University of Padova, 35121, Padova, Italy.
Ioannis S PaterasMolecular Carcinogenesis Group, Department of Histology and Embryology, School of Medicine, National Kapodistrian University of Athens, 75 Mikras Asias Str, GR-11527, Athens, Greece.
Umakanta SwainDepartment of Biomolecular Sciences, Weizmann Institute of Science, 76100, Rehovot, Israel.
Vassilis L SouliotisInstitute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, 48 Vassileos Constantinou Ave, GR-11635, Athens, Greece.
Alexandros G GeorgakilasPhysics Department, School of Applied Mathematical and Physical Sciences, National Technical University of Athens (NTUA), 15780, Zografou, Athens, Greece.
Nicholas GeacintovDepartment of Chemistry, New York University, New York, 10012, USA.
Luca ScorranoDepartment of Biology, University of Padova, 35121, Padova, Italy.
Claudia LukasNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Jiri LukasNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Zvi LivnehDepartment of Biomolecular Sciences, Weizmann Institute of Science, 76100, Rehovot, Israel.
Zoi LygerouLaboratory of Biology, School of Medicine, University of Patras, 26505, Patras, Rio, Greece.
Dipanjan ChowdhuryDepartment of Radiation Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.
Claus Storgaard SørensenBiotech Research and Innovation Centre (BRIC), University of Copenhagen, Ole Maaloes Vej 5, DK-2200, Copenhagen, Denmark.
Jiri BartekDanish Cancer Society Research Centre, Strandboulevarden 49, DK-2100, Copenhagen, Denmark. jb@cancer.dk.
Vassilis G GorgoulisMolecular Carcinogenesis Group, Department of Histology and Embryology, School of Medicine, National Kapodistrian University of Athens, 75 Mikras Asias Str, GR-11527, Athens, Greece. vgorg@med.uoa.gr.
National and Kapodistrian University of Athens · GRUniversity of Copenhagen · DKUniversity of Padua · ITUniversity of Patras · GRWeizmann Institute of Science · ILAcademy of Athens · GRHarvard University · USNational Hellenic Research Foundation · GRNational Technical University of Athens · GRNew York University · USScience for Life Laboratory · SE

Funding

Danish National Research Foundation CARDHorizon 2020 722729
6 · The paper itself

Abstract

backgroundGenomic instability promotes evolution and heterogeneity of tumors. Unraveling its mechanistic basis is essential for the design of appropriate therapeutic strategies. In a previous study, we reported an unexpected oncogenic property of p21

resultsWe now demonstrate that p21

conclusionsOur results signify the importance of mutational signatures as guides to disclose the repair history leading to genomic instability. We unveil how chronic p21

Indexed as

DNA RepairGenomic InstabilityMutationCell LineCyclin-Dependent Kinase Inhibitor p21DNAHumansRad52 DNA Repair and Recombination ProteinTumor Suppressor Protein p53CDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21DNARad52 DNA Repair and Recombination ProteinTumor Suppressor Protein p53Break-induced replication (BIR)Genomic instabilityp21WAF1/Cip1Rad52Single nucleotide substitution (SNS)Single strand annealing (SSA)Translesion DNA synthesis (TLS)

Identifiers

PMID29548335
PMCPMC5857109
OpenAlexW2757613651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.